Exagamglogene autotemcel
id:
exagamglogene-autotemcel-183-17062929
title:
Exagamglogene autotemcel
text:
Exagamglogene autotemcel, sold under the brand name Casgevy, is a gene therapy used for the treatment of sickle cell disease and transfusion-dependent beta thalassemia. It was developed by Vertex Pharmaceuticals and CRISPR Therapeutics. The most common side effects include low levels of platelets and white blood cells, mouth sores, nausea, musculoskeletal pain, abdominal pain, vomiting, febrile neutropenia, headache, and itching. The treatment was approved in the United Kingdom for the treatment
brand slug:
wiki
category slug:
encyclopedia
description:
Gene therapy
original url:
https://en.wikipedia.org/wiki/Exagamglogene_autotemcel
date created:
2023-12-04T21:49:27Z
date modified:
2024-09-07T04:01:05Z
main entity:
{"identifier":"Q107400400","url":"https://www.wikidata.org/entity/Q107400400"}
image:
fields total:
13
integrity:
15